Transgenomic ROA 2010-2023 | PRPO
Current and historical return on assets (ROA) values for Transgenomic (PRPO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Transgenomic ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2023-12-31 |
$-0.01B |
$0.02B |
-26.67% |
| 2023-09-30 |
$-0.01B |
$0.02B |
-40.51% |
| 2023-06-30 |
$-0.01B |
$0.02B |
-47.62% |
| 2023-03-31 |
$-0.01B |
$0.02B |
-43.96% |
| 2022-12-31 |
$-0.01B |
$0.02B |
-48.00% |
| 2022-09-30 |
$-0.01B |
$0.02B |
-44.44% |
| 2022-06-30 |
$-0.01B |
$0.03B |
-37.93% |
| 2022-03-31 |
$-0.01B |
$0.03B |
-38.71% |
| 2021-12-31 |
$-0.01B |
$0.03B |
-27.59% |
| 2021-09-30 |
$-0.01B |
$0.03B |
-29.91% |
| 2021-06-30 |
$-0.01B |
$0.03B |
-37.50% |
| 2021-03-31 |
$-0.01B |
$0.02B |
-39.51% |
| 2020-12-31 |
$-0.01B |
$0.02B |
-70.00% |
| 2020-09-30 |
$-0.02B |
$0.02B |
-81.01% |
| 2020-06-30 |
$-0.02B |
$0.02B |
-74.07% |
| 2020-03-31 |
$-0.02B |
$0.02B |
-90.48% |
| 2019-12-31 |
$-0.01B |
$0.02B |
-64.37% |
| 2019-09-30 |
$-0.02B |
$0.02B |
-76.40% |
| 2019-06-30 |
$-0.02B |
$0.02B |
-83.52% |
| 2019-03-31 |
$-0.02B |
$0.02B |
-67.37% |
| 2018-12-31 |
$-0.02B |
$0.02B |
-80.81% |
| 2018-09-30 |
$-0.03B |
$0.03B |
-100.00% |
| 2018-06-30 |
$-0.03B |
$0.03B |
-112.28% |
| 2018-03-31 |
$-0.04B |
$0.03B |
-121.60% |
| 2017-12-31 |
$-0.03B |
$0.03B |
-132.00% |
| 2017-09-30 |
$-0.02B |
$0.04B |
-102.70% |
| 2017-06-30 |
$-0.01B |
$0.04B |
-87.80% |
| 2017-03-31 |
$0.00B |
$0.00B |
0.00% |
| 2016-12-31 |
$-0.00B |
$0.00B |
-120.00% |
| 2016-09-30 |
$-0.02B |
$0.00B |
-685.71% |
| 2016-06-30 |
$-0.03B |
$0.00B |
-355.56% |
| 2016-03-31 |
$-0.04B |
$0.00B |
-218.75% |
| 2015-12-31 |
$-0.03B |
$0.01B |
-144.68% |
| 2015-09-30 |
$-0.02B |
$0.02B |
-67.23% |
| 2015-06-30 |
$-0.01B |
$0.03B |
-38.10% |
| 2015-03-31 |
$-0.01B |
$0.03B |
-41.27% |
| 2014-12-31 |
$-0.01B |
$0.03B |
-45.53% |
| 2014-09-30 |
$-0.01B |
$0.03B |
-39.02% |
| 2014-06-30 |
$-0.02B |
$0.03B |
-57.60% |
| 2014-03-31 |
$-0.02B |
$0.03B |
-51.13% |
| 2013-12-31 |
$-0.02B |
$0.03B |
-47.55% |
| 2013-09-30 |
$-0.02B |
$0.03B |
-39.47% |
| 2013-06-30 |
$-0.01B |
$0.04B |
-29.63% |
| 2013-03-31 |
$-0.01B |
$0.04B |
-23.81% |
| 2012-12-31 |
$-0.01B |
$0.04B |
-20.69% |
| 2012-09-30 |
$-0.01B |
$0.04B |
-16.57% |
| 2012-06-30 |
$-0.01B |
$0.05B |
-15.38% |
| 2012-03-31 |
$-0.01B |
$0.05B |
-30.99% |
| 2011-12-31 |
$-0.01B |
$0.03B |
-34.92% |
| 2011-09-30 |
$-0.01B |
$0.03B |
-38.71% |
| 2011-06-30 |
$-0.01B |
$0.03B |
-40.74% |
| 2011-03-31 |
$-0.01B |
$0.03B |
-26.37% |
| 2010-12-31 |
$-0.00B |
$0.03B |
-15.79% |
| 2010-09-30 |
$-0.00B |
$0.01B |
-13.33% |
| 2010-06-30 |
$-0.00B |
$0.01B |
-6.56% |
| 2010-03-31 |
$-0.00B |
$0.02B |
-6.35% |
| 2009-12-31 |
$-0.00B |
$0.02B |
-12.50% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.010B |
$0.015B |
|
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
|
